Exodus Point Capital Management, LP 2seventy Bio, Inc. Transaction History
Exodus Point Capital Management, LP
- $14.7 Billion
- Q2 2024
A detailed history of Exodus Point Capital Management, LP transactions in 2seventy Bio, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 25,161 shares of TSVT stock, worth $113,476. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,161Holding current value
$113,476% of portfolio
0.0%Shares
9 transactions
Others Institutions Holding TSVT
# of Institutions
120Shares Held
48.1MCall Options Held
211KPut Options Held
9.7K-
Kynam Capital Management, LP Princeton, NJ5.95MShares$26.9 Million1.78% of portfolio
-
Goldman Sachs Group Inc New York, NY4.14MShares$18.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.66MShares$16.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.63MShares$16.4 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.27MShares$14.8 Million0.0% of portfolio
About 2seventy bio, Inc.
- Ticker TSVT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,873,600
- Market Cap $171M
- Description
- 2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...